The Melanoma Tissue Bank Consortium скачать в хорошем качестве

The Melanoma Tissue Bank Consortium

It's one of the fastest growing cancers in the United States and worldwide. It's one of the most complex forms of cancer. It has the most mutations of all solid cancers. Its rate in the pediatric population has tripled in the last 10 years. Yet melanoma research lags behind that of other cancers. AIM at Melanoma intends to change that. AIM is boldly doing something that no other research institution, foundation, or medical center has done for melanoma. AIM has brought together five esteemed institutions and researchers to establish the first collaborative melanoma tissue bank consortium. Together, we are collecting more than 500 fresh-frozen primary melanoma tissue samples and corresponding patient data—and then performing much needed research with those samples to answer some of melanoma's most critical questions: Who will develop melanoma, and why? Whose melanomas will spread and become deadly? Which drugs will work on which patients? Ultimately, the melanoma tissue bank will help us make significant progress toward finding the cure.